BAB VI SIMPULAN DAN SARAN
B. Saran
1. Dilakukan penelitian serupa dengan jangka waktu yang lebih lama. 2. Menggunakan kurkumin yang tidak mengandung zat-zat lain
3. Dilakukan variasi dosis kurkumin untuk mengetahui dosis yang paling efektif pada hewan coba.
4. Dilakukan variasi jalur pemberian kurkumin pada hewan coba.
5. Penelitian lebih lanjut mengenai pengaruh kurkumin pada sepsis menggunakan parameter lain misalnya biomarker sepsis, sitokin-sitokin proinflamasi dan antiinflamasi, serta marker-marker apoptosis lain.
xxxvii
DAFTAR PUSTAKA
Aggarwal BB, Kumar A, and Bharti AC. 2003. Anticancer Potential of Kurkumin : Preclinical and Clinical Studies. Anticancer Research. 23:363-398
Aggarwal BB and Shishodia S. 2004. Suppression of the Nuclear Factor-kappa B Activation Pathway by Spice-Derived Phytochemicals: Reasoning for Seasoning. Ann N Y Acad Sci. Dec;1030:434-41. Arbiser JL, N Klauber, R Rohan, R Van Leewen, MT Huang, C Fisher, E
Flynn, and HR Byers. 1998. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. June; 4(6): 376–383
Arkeman H dan David. 2006. Efek Vitamin C dan E Terhadap Sel Goblet Saluran Napas pada Tikus Akibat Pajanan Asap Rokok. Universa. Vol. 25, No. 2
Bochud PY and Chalandra T. 2003. Pathogenesis of Sepsis : New Concept and Implications for Future Treatment. BMJ. 326:262-6
Budiarto E. 2001. Biostatistik untuk Kedokteran dan Kesehatan Masyarakat. EGC. Jakarta
Brahmbhatt S, Gupta A, and Sharma AC. 2005. Bigendothelin-1 (1-21) fragment during Early Sepsis Modulates tau, p38-MAPK phosphorylation and Nitric Oxide Synthase Activation. Molecular and Cellular Biochemistry. 271:225–237
Chattopadhyay I, Kaushik B, Uday B, and Ranajit K.B. 2004. Turmeric and curcumin: Biological actions and medicinal applications. Current Science, July; 87:1-10
Chopra M and Sharma AC. 2007. Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sci. July; 81(4): 306–316
Commandeur JN and Vermeulen NP. 1996. Cytotoxicity and Cytoprotective Activities of Natural Compounds. The Case of Curcumin. Xenobiotica 26 : 667 - 680.
xxxviii
Diding HP dan Subijanto AA. 2008. Efek Probiotik Terhadap Kelangsungan Hidup dan Hitung Limfosit pada Mencit Model Sepsis. Jurnal Kedokteran Medicina. Mei; 39(2):149-152
Edwin SVA, Theo JCVB, and Johan K. 2003. Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin Microbiol Rev. July; 16(3): 379–414.
Elena GR, Alejo C, Gema R, and Mario D. 2006. Cortistatin, a New Antiinflammatory Peptide with Therapeutic Effect on Lethal Endotoxemia. J Exp Med. March; 203(3): 563–571.
Eny DW. 2004. Sepsis di Ruang Rawat Inap Tipe Kelas dan Paviliun Bangsal Penyakit Dalam RSUD Dr. Moewardi Surakarta Tahun 2002. Skripsi FK-UNS. Surakarta
Hermawan GA. 2006. Penyakit Tropik dan Infeksi: Sepsis. In: Buku Ajar Ilmu Penyakit Dalam jilid III Edisi IV. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI, Hal:1840-1843.
Hermawan GA. 2008. SIRS, SEPSIS dan SYOK SEPTIK (Imunologi, Diagnosis dan Penatalaksanaan). Sebelas Maret University Press. Surakarta.
Hatcher H, Planalp R, Cho, Torti FM, and Torti SV. 2008. Kurkumin : From Ancient Medicine To Current Clinical Trials. Cell. Mol. Life Sci. 65:1631-1652
Hsu CH and Cheng AL. 2007. "Clinical studies with kurkumin". Adv. Exp. Med. Biol. 595: 471-80
Ireson CR, Jones DJL, Orr S, Coughtrie MWH, Boocock DJ, Williams ML et al. 2002. Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine. Cancer Epidemiology Biomarkers & Prevention. January. 11:105-111 Jacob A, Rongqian Wu, Mian Zhou, and Ping Wang. 2007. Mechanism of
the Anti-inflammatory Effect of Curcumin: PPAR-γ Activation. Hindawi Publishing Corporation PPAR Research. Volume 2007. Jagetia G and Aggarwal BB. 2007.“Spicing Up” of the Immune System by
Kurkumin. Journal of Clinical Immunology. January; 27: 1. James MJ, Naeem AA, and Edward A. 2005. Year in review in Critical
Care, 2004: Sepsis and Multi-Organ Failure. Crit Care. 9(4): 409–413.
xxxix
Jiao Y, Wilkinson J, and Di X. 2009. "Kurkumin, a Cancer Chemopreventive and Chemotherapeutic Agent, is a Biologically Active Iron Chelator". Blood 113 (2): 462-9.
Joe B, M Vijaykumar, and BR Lokesh. 2004. Biological Properties of Curcumin - Cellular and Molecular Mechanisms of Action. Critical Review in Food Science and Nutrition. 44 (2) : 97-112. John CM. 2002. The International Sepsis Forum’s controversies in sepsis:
how will sepsis be treated in 2051?. Critical Care , 6:465-467 Jones DO. 2007. Crash course pathology.2thed. St Louis: C.V.Mosby
Co.,p:17.
Jürgen B, Edda K, Claudia DS, Björn L, Patrick S, Ortrud V et al. 2006. Effects of dopexamine on the intestinal microvascular blood flow and leucocyte activation in a sepsis model in rats. Crit Care.10(4): R117.
Karlsson S, Varpula M, Ruokonen E, Petila V, Parviainen I, Ala-kokko T. I, Kolho E, and Rintala EM. 2007. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med. 33:435-443.
Kristine MJ, Sarah BL, Anncatrine LP, Jesper EO, and Thomas B. 2007. Common TNF-α, IL-1β, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis. 7: 108. Oscar C, Andrea G, Roberto G, Cristina B, Fiorenza O, Carmela S et al.
2006. LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria. Antimicrob Agents Chemother. May; 50(5): 1672–1679.
Padma, TV. 2005. "Turmeric Can Combat Malaria, Cancer Virus and HIV".SciDev.net.
http://www.scidev.net/News/index.cfm?fuseaction=readNews&it emid=1987&language=1. (7 September 2009).
Pudjiastuti. 2008. Imunoglobulin Intravena pada Anak dan Bayi dengan Sepsis. Kumpulan Makalah. National Symposium: the 2nd Indonesian Sepsis Forum. Surakarta, March 7th–9th; pp:100 Pierre YB and Thierry C. 2003. Pathogenesis of sepsis: new concepts and
xl
Riedemann NC, Guo RF, and Ward PA. 2003. The Enigma of Sepsis. J. Clin. Invest. August 15th;112(4): 460-467
Russel JA. 2006. Management of Sepsis. N Engl J Med. October 19th; 355:1699-1713
Shahin G, Ole GK, Court P, and Svend SP. 2006. Procalcitonin, lipopolysaccharide-binding protein,interleukin-6 and C-reactive protein in community-acquired infectios and sepsis: a prospective study. Critical care, 10:R53
Shukla PK, Khanna VK, Ali MM, Khan MY and Srimal RC. 2008. Anti-ischemic effect of kurkumin in rat brain, Neurochem Res. Epub. Jun;33(6):1036-43.
Suhardjono D. 1995. Percobaan Hewan Laboratorium. Yogyakarta: Gadjah Mada University Press, hal: 207.
Wesche DE, Joanne LLN, Perl M, Chung CS and Ayala A. 2005. Leukocyte Apoptosis And Its Significance In Sepsis And Shock. Journal of Leukocyte Biology.78:325-337
World Health Organization. 2003. Traditional medicine,
http://www.who.int/mediacentre/factsheets/fs134/en/ ( 03 juni 2010)
Xiao H, Siddiqui J, and Remick DG. 2006. Mechanisms of Mortality in Early and Late Sepsis. J Infection And Immunity, Sept;74(9):5227–5235
